Scholars Central

ArticlePublished 2011

The Use of Nasojejunal Nutrition in Patients with Chronic Pancreatitis

Authors: James Robert Anthony Skipworth, Dimitri Aristotle Raptis, Shalini Wijesuriya, Zudin Puthucheary, Steven WM Olde Damink, Charles Imber, Massimo Malagò, Arjun Shankar

Journal of the Pancreas

Volume 12 · Issue 6

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Context Abdominal pain, malabsorption and diabetes all contribute to a negative impact upon nutritional status in chronic pancreatitis and no validated standard for the nutritional management of patients exists. Objective To assess the effect of nasojejunal nutrition in chronic pancreatitis patients. Design All consecutive chronic pancreatitis patients fed via the nasojejunal route between January 2004 and December 2007 were included in the study. Patients were assessed via retrospective review of case notes. Results Fifty-eight chronic pancreatitis patients (35 males, 23 females; median age 46 years) were included. Patients were discharged after a median of 14 days and nasojejunal nutrition continued for a median of 47 days. Forty-six patients (79.3%) reported resolution of their abdominal pain and cessation of opioid analgesia intake over the study period and median weight gain at 6 weeks following nutritional cessation was +1 kg (range -24 to +27 kg; P=0.454). Twelve (20.7%) patients reported recurrence of their pain during the follow-up period and complications were both minor and infrequent. Significant improvements were noted in most blood parameters measured, including: sodium (from 134.8 to 138.1 mEq/L; P<0.001); urea (from 3.4 to 5.1 mmol/L; P<0.001); creatinine (from 58.3 to 60.3 μmol/L; P<0.001); corrected calcium (from 2.24 to 2.35 mmol/L; P=0.018); albumin (from 34.5 to 38.7 g/L; P=0.002); CRP (from 73.0 to 25.5 mg/L; P=0.006); and haemoglobin (from 11.8 to 12.4 g/dL; P=0.036). Conclusion Nasojejunal nutrition, commenced in hospital and continued at home, is safe, efficacious and well tolerated in patients with severe chronic pancreatitis and is effective in helping to relieve pain and diminish analgesic requirements.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of the Pancreas.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of the Pancreas
  • SubjectGastroenterology & Hepatology
  • BylineArticles whose byline prints “James Robert Anthony Skipworth”
  • BylineArticles whose byline prints “Dimitri Aristotle Raptis”
  • BylineArticles whose byline prints “Shalini Wijesuriya”
  • BylineArticles whose byline prints “Zudin Puthucheary”
  • BylineArticles whose byline prints “Steven WM Olde Damink”
  • BylineArticles whose byline prints “Charles Imber”
  • BylineArticles whose byline prints “Massimo Malagò”
  • BylineArticles whose byline prints “Arjun Shankar”